IRIS
BRANCACCIO, DIEGO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.576
NA - Nord America 3.217
EU - Europa 2.933
SA - Sud America 383
Continente sconosciuto - Info sul continente non disponibili 220
AF - Africa 108
OC - Oceania 6
Totale 10.443
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.085
SG - Singapore 1.466
RU - Federazione Russa 1.216
IT - Italia 947
CN - Cina 741
VN - Vietnam 663
BR - Brasile 301
HK - Hong Kong 230
DE - Germania 122
NL - Olanda 118
FR - Francia 112
GB - Regno Unito 93
BD - Bangladesh 83
JP - Giappone 83
CA - Canada 79
FI - Finlandia 78
IN - India 69
IE - Irlanda 63
CI - Costa d'Avorio 49
SE - Svezia 44
KR - Corea 37
AR - Argentina 36
PH - Filippine 31
IQ - Iraq 29
PL - Polonia 27
MX - Messico 26
TH - Thailandia 25
ES - Italia 23
ID - Indonesia 21
UA - Ucraina 21
TR - Turchia 20
ZA - Sudafrica 18
BE - Belgio 12
EC - Ecuador 11
MY - Malesia 11
TW - Taiwan 11
AT - Austria 10
CO - Colombia 9
JM - Giamaica 8
MA - Marocco 8
PY - Paraguay 8
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
EG - Egitto 6
LT - Lituania 6
SA - Arabia Saudita 6
SN - Senegal 6
GR - Grecia 5
JO - Giordania 5
KZ - Kazakistan 5
MD - Moldavia 5
PE - Perù 5
PK - Pakistan 5
BG - Bulgaria 4
CR - Costa Rica 4
ET - Etiopia 4
NP - Nepal 4
VE - Venezuela 4
AU - Australia 3
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
CH - Svizzera 3
GT - Guatemala 3
IR - Iran 3
KE - Kenya 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
OM - Oman 3
PS - Palestinian Territory 3
RO - Romania 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AL - Albania 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
HN - Honduras 2
HR - Croazia 2
IL - Israele 2
MK - Macedonia 2
MU - Mauritius 2
PA - Panama 2
PR - Porto Rico 2
RS - Serbia 2
SI - Slovenia 2
YT - Mayotte 2
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
DJ - Gibuti 1
DZ - Algeria 1
GA - Gabon 1
GM - Gambi 1
KH - Cambogia 1
LY - Libia 1
ME - Montenegro 1
MM - Myanmar 1
NG - Nigeria 1
Totale 10.219
Salva come PNG Salva come JPEG
Città #
Singapore 680
San Jose 565
Ashburn 311
Naples 291
Moscow 282
Chandler 266
Beijing 244
Hong Kong 217
Ho Chi Minh City 207
Dallas 166
Santa Clara 148
Hefei 133
Hanoi 128
Amsterdam 110
Los Angeles 109
Napoli 96
Tokyo 74
Lauterbourg 70
Millbury 62
New York 56
Nanjing 52
Boston 50
Princeton 47
São Paulo 46
Munich 44
The Dalles 44
Des Moines 40
Buffalo 35
Rome 35
Seattle 32
Brooklyn 27
Milan 26
Warsaw 26
Redondo Beach 25
Da Nang 24
Seoul 24
Ottawa 23
Turku 22
Haiphong 21
Orem 21
Chicago 19
Denver 19
Frankfurt am Main 17
Bangkok 16
Lawrence 16
Toronto 16
Helsinki 15
Jacksonville 15
Montreal 15
Poplar 15
Stockholm 15
Dong Ket 14
Phoenix 14
Florence 13
Hải Dương 13
Atlanta 12
Charlotte 12
Houston 12
Manchester 12
Nanchang 12
Baghdad 11
Biên Hòa 11
London 11
Mexico City 11
Rio de Janeiro 11
Tianjin 11
Brussels 10
Council Bluffs 10
Shenyang 10
Wilmington 10
Bologna 9
Chennai 9
Dearborn 9
Düsseldorf 9
Hebei 9
Ninh Bình 9
Nuremberg 9
Pittsburgh 9
San Francisco 9
San Giorgio a Cremano 9
Secaucus 9
Ankara 8
Dublin 8
Jiaxing 8
Augusta 7
Changsha 7
Falkenstein 7
Guangzhou 7
Johannesburg 7
Porto Alegre 7
Salerno 7
Torre del Greco 7
Washington 7
Belfast 6
Bengaluru 6
Birmingham 6
Hangzhou 6
Kingston 6
Kochi 6
Kuala Selangor 6
Totale 5.505
Salva come PNG Salva come JPEG
Nome #
Functional Selectivity Revealed by N-Methylation Scanning of Human Urotensin II and Related Peptides 237
1H NMR-based metabolomics study on follicular fluid from patients with Polycystic Ovary Syndrome 221
Urokinase receptor derived peptides as potent inhibitors of the formyl peptide receptor type 1-triggered cell migration 202
Computer-Aided Identification and Lead Optimization of Dual Murine Double Minute 2 and 4 Binders: Structure-Activity Relationship Studies and Pharmacological Activity 199
[4Fe-4S] cluster assembly in mitochondria and its impairment by copper 194
Unveiling the biological effects of DNA G-quadruplex ligands through multi-omics data integration 188
Antimicrobial peptide Temporin-L complexed with anionic cyclodextrins results in a potent and safe agent against sessile bacteria 184
Alanine scanning analysis and structure-function relationships of the frog-skin antimicrobial peptide temporin-1Ta 177
Interfering with the Tumor-Immune Interface: Making Way for Triazine-Based Small Molecules as Novel PD-L1 Inhibitors 174
Discovery of 2,3-Diaminoindole Derivatives as a Novel Class of NOD Antagonists 173
Common G-quadruplex binding agents found to interact with i-motif-forming DNA: Unexpected multi-target-directed compounds 170
Discovery of Novel Potent and Selective Agonists at the Melanocortin-3 Receptor 170
A nutraceutical formulation based on Annurca apple polyphenolic extract is effective on intestinal cholesterol absorption: A randomised, placebo-controlled, crossover study 168
Exploring the N-Terminal Region of C-X-C Motif Chemokine 12 (CXCL12): Identification of Plasma-Stable Cyclic Peptides As Novel, Potent C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonists 163
The Outcomes of Decorated Prolines in the Discovery of Antimicrobial Peptides from Temporin-L 161
Glycine-replaced derivatives of [Pro3,DLeu9]TL, a temporin L analogue: Evaluation of antimicrobial, cytotoxic and hemolytic activities 155
Insights into telomeric G-quadruplex DNA recognition by HMGB1 protein 155
An investigation into the origin of the biased agonism associated with the urotensin II receptor activation 154
Structure-Activity Relationships and Biological Characterization of a Novel, Potent, and Serum Stable C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonist 154
Monitoring the effect of antagonist on P53-MDM2 interaction with NMR spectroscopy. Recent results 148
Sensitization of melanoma cells to standard chemotherapy: G-quadruplex binders as synergistic agents 146
Theoretical and experimental studies on the interaction of biphenyl ligands with human and murine PD-L1: Up-to-date clues for drug design 143
Disulfide bond replacement with 1,4‐ and 1,5‐disubstituted [1,2,3]‐triazole on C‐X‐C chemokine receptor type 4 (CXCR4) peptide ligands: small changes that make big differences 142
Structure-based lead optimization and biological evaluation of BAX direct activators as novel potential anticancer agents 139
Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors 139
Deepening bis-(thio)carbohydrazones conformational dynamics and hydrogen bond interactions in a non-protic solvent: DFT, molecular dynamics, NMR, and Raman investigations 137
Enriching the arsenal of pharmacological tools against mical2 137
Design, Synthesis, and Cytotoxic Evaluation of AcylDerivatives of 3-Aminonaphtho[2,3-b]thiophene-4,9-dione, a Quinone-Based System 136
A combined approach of structure‐based virtual screening and NMR to interrupt the PD‐1/PD‐L1 axis: Biphenyl‐benzimidazole containing compounds as novel PD‐L1 inhibitors 135
Simultaneous Targeting of RGD-Integrins and Dual Murine Double Minute Proteins in Glioblastoma Multiforme 133
Breast tumor cell invasion and pro-invasive activity of cancer-associated fibroblasts co-targeted by novel urokinase-derived decapeptides 133
Visible Light-promoted C(sp3)-H α-Carbamoylation of Cyclic Ethers with Isocyanides 131
Structure-Activity Study of the Peptides P5U and Urantide by the Development of Analogues Containing Uncoded Amino Acids at Position9 131
New insight into the binding mode of peptides at urotensin-II receptor by Trp-constrained analogues of P5U and urantide. 129
Assessing the influence of pH and cationic strength on i-motif DNA structure 129
First-in-Class Cyclic Temporin L Analogue: Design, Synthesis, and Antimicrobial Assessment 128
Design, synthesis, and conformational analysis of Melanotropin analogues of MTII and SHU9119. 127
Synthesis and characterization of bis-triazolyl-pyridine derivatives as noncanonical DNA-interacting compounds 127
An unbiased lncRNAs dropout CRISPR-Cas9 screen reveals RP11-350G8.5 as a novel therapeutic target for Multiple Myeloma 126
Design, Synthesis, and Conformational Analysis of Melanotropin Analogues of MTII and SHU9119 126
NEW INSIGHT INTO THE BINDING MODE OF CYCLIC MELANOCORTIN LIGANDS AT THE MC4 RECEPTOR 126
Glioblastoma Cell Migration, Invasion and Vasculogenic Mimicry Downmodulated by Novel uPAcyclin Derivatives 124
Ligand-Based NMR Study of C-X-C Chemokine Receptor Type 4 (CXCR4)-Ligand Interactions on Living Cancer Cells 124
From a Helix to a Small Cycle: Metadynamics-Inspired αvβ6 Integrin Selective Ligands 124
Structure- and conformation-activity studies of nociceptin/orphanin FQ receptor dimeric ligands 122
A novel β-hairpin peptide derived from the ARC repressor selectively interacts with the major groove of B-DNA 121
Photomicellar Catalyzed Synthesis of Amides from Isocyanides: Optimization, Scope, and NMR Studies of Photocatalyst/Surfactant Interactions 119
NMR analysis of synthetic peptides agonist to PTPRJ, a receptor-type protein tyrosine phosphatase with tumor suppressor activity 119
Novel octreotide dicarba-analogues with high affinity and different selectivity for somatostatin receptors 118
Urantide Conformation and Interaction with the Urotensin-II Receptor 118
[2Fe-2S] cluster transfer in iron-sulfur protein biogenesis 118
New Anticancer Agents Mimicking Protein Recognition Motifs. 117
HOPPI-NMR: Hot-Peptide-Based Screening Assay for Inhibitors of Protein-Protein Interactions by NMR 117
NMR analysis of synthetic peptides agonist to PTPRJ, a receptor-type protein tyrosine phosphatase with tumor suppressor activity. 116
Structure-Activity Relationship, Conformational and Biological Studies of Temporin L Analogues 116
Design, synthesis and characterization of aryl bis-guanyl hydrazones as RNA binders of C9orf72 G4C2 extended repeats 114
Discovery of pyrrole derivatives for the treatment of glioblastoma and chronic myeloid leukemia 114
Conformational study on cyclic melanocortin ligands and new insight into their binding mode at the MC4 receptor 112
A De Novo Designed Library of Linear Helical Peptides: An Exploratory Tool in the Discovery of Protein-Protein Interaction Modulators 112
Sar Study Of P5u And Urantide Analogues Modified At Position 9 112
Role of Lipoylation of the Immunodominant Epitope of Pyruvate Dehydrogenase Complex: Toward a Peptide-Based Diagnostic Assay for Primary Biliary Cirrhosis 112
Identification of the Spiro(oxindole-3,3’-thiazolidine)-Based Derivatives as Potential p53 Activity Modulators 111
Structure-Activity Relationship Studies, SPR Affinity Characterization, and Conformational Analysis of Peptides That Mimic the HNK-1 Carbohydrate Epitope 110
Synthesis and pharmacological evaluation of some 4-oxo-quinoline-2-carboxylic acid derivatives as anti-inflammatory and analgesic agents 109
SAR Study on CN17β a Potent and Selective CaMKII Peptide Inhibitor 99
Development of linear β-turn inducers containing peptides as arc mimetics with DNA topological and sequence selectivity 88
Arylazo Sulfones as 1,3-Dipole Acceptors in the (Photo)-Micellar van Leusen Triazole Synthesis 86
Formation of [4Fe-4S] clusters in the mitochondrial iron-sulfur cluster assembly machinery 84
Constrained Peptides with Fine-Tuned Flexibility Inhibit NF-Y Transcription Factor Assembly 83
New insight into the binding mode of peptide ligands at Urotensin-II receptor: structure-activity relationships study on P5U and urantide 83
New insight into the binding mode of cyclic melanocortin ligands at the MC4 receptor 83
Retromer stabilization results in neuroprotection in a model of Amyotrophic Lateral Sclerosis 82
Synthesis of dicarba-cyclooctapeptide Somatostatin analogs by conventional and MW-assisted RCM: A study about the impact of the configuration at C α of selected amino acids 79
Strategic Single-Residue Substitution in the Antimicrobial Peptide Esc(1-21) Confers Activity against Staphylococcus aureus, Including Drug-Resistant and Biofilm Phenotype. 78
Role of Helical Structure in MBP Immunodominant Peptides for Efficient IgM Antibody Recognition in Multiple Sclerosis 76
Temporin g, an amphibian antimicrobial peptide against influenza and parainfluenza respiratory viruses: Insights into biological activity and mechanism of action 71
Discovery of PTPRJ agonist peptides that effectively inhibit in vitro cancer cell proliferation and tube formation. 69
DOTA-Derivatives of Octreotide Dicarba-Analogs with High Affinity for Somatostatin sst2,5 Receptors 69
To bind or not to bind: diagnosing false positives for 1:1 binding to G-Protein 65
PEGylation-Driven Remodeling of the Protein Corona on PLGA Nanoparticles: Implications for Macrophage Recognition 63
Opposite modulation of cell migration by distinct subregions of urokinase connecting peptide 63
Sar Study Of P5u And Urantide Analogues Modified At Position 9 60
Coupling PD-L1 Inhibition and Lysosomal Degradation: Innovative Anti-PD-L1 Peptides for NSCLC Immunotherapy 15
PEG-lipid structure controls in vitro PEG shedding, surface remodeling, and timing of lipid nanoparticle-mediated silencing 14
Enhancing Non-small Cell Lung Cancer Susceptibility to Anti-PD-1/PD-L1 Therapy through PD-L1 Ligand–Ir(III) Complex Conjugates 4
Structure-Guided Design of Temporin-Derived Peptides Reveals Potent Dual-Mechanism Inhibitors of SARS-CoV-2 3
Totale 10.443
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.733
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.733
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022416 0 6 13 7 23 4 7 14 68 51 71 152
2022/2023660 66 40 35 57 85 71 7 61 99 93 33 13
2023/2024487 23 73 86 26 31 32 8 89 11 9 72 27
2024/20252.602 103 88 13 43 47 199 253 174 176 290 984 232
2025/20265.368 547 422 676 491 859 223 649 263 552 347 197 142
2026/2027114 97 17 0 0 0 0 0 0 0 0 0 0
Totale 10.443